Status:
RECRUITING
Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy
Lead Sponsor:
Hospital Clinic of Barcelona
Collaborating Sponsors:
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV)
Conditions:
Conduction System Pacing
Conventional Ventricular Pacing
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and...
Detailed Description
Pacemaker implantation and conventional cardiac stimulation from the right ventricle is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia. But it ...
Eligibility Criteria
Inclusion
- The patient must be ≥ 18 years of age.
- The patient must indicate their acceptance to participate in the study by signing an informed consent document.
- Patients with EF\> 50% and indication for pacemaker implantation due to atrial-ventricular block according to current clinical guidelines.
Exclusion
- Inability to understand and sign the informed consent.
- Patients with severe comorbidities and life expectancy \<1 year.
- Patients with severe cognitive impairment or other comorbidities resulting in dependence for basic activities of daily life.
- Patients who cannot come to our center to carry out the follow-up of the study.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05214365
Start Date
February 1 2022
End Date
September 1 2026
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic of Barcelona
Barcelona, Spain, 08036